Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAmortizatization of IntangiblesAmortizatization of IntangiblesCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in IntangiblesChange in IntangiblesChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Verastem (VSTM) Gains from Sales and Divestitures (2019 - 2025)

Verastem has reported Gains from Sales and Divestitures over the past 7 years, most recently at $687067.0 for Q4 2025.

  • Quarterly results put Gains from Sales and Divestitures at $687067.0 for Q4 2025, up 1667.28% from a year ago — trailing twelve months through Dec 2025 was $687067.0 (up 1667.28% YoY), and the annual figure for FY2025 was $687067.0, up 1667.28%.
  • Gains from Sales and Divestitures for Q4 2025 was $687067.0 at Verastem, up from $642000.0 in the prior quarter.
  • Over the last five years, Gains from Sales and Divestitures for VSTM hit a ceiling of $5.3 million in Q4 2022 and a floor of $14279.0 in Q1 2024.
  • Median Gains from Sales and Divestitures over the past 5 years was $110304.0 (2021), compared with a mean of $519920.4.
  • Biggest five-year swings in Gains from Sales and Divestitures: soared 5320.66% in 2022 and later tumbled 99.43% in 2023.
  • Verastem's Gains from Sales and Divestitures stood at $97812.0 in 2021, then soared by 5320.66% to $5.3 million in 2022, then tumbled by 99.43% to $30128.0 in 2023, then rose by 29.04% to $38877.0 in 2024, then surged by 1667.28% to $687067.0 in 2025.
  • The last three reported values for Gains from Sales and Divestitures were $687067.0 (Q4 2025), $642000.0 (Q3 2025), and $591731.0 (Q2 2025) per Business Quant data.